|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 92 No. 10 (November 15), 1998:
pp. 3658-3668
Growth and Differentiation of Human Stem Cell
Factor/Erythropoietin-Dependent Erythroid Progenitor Cells In Vitro
Birgit Panzenböck,
Petr Bartunek,
Markus Y. Mapara, and
Martin Zenke
From the Max-Delbrück-Centre for Molecular Medicine, MDC,
Berlin, Germany; and the Humboldt University Berlin, Virchow Klinikum,
Robert-Rössle-Klinik, Berlin, Germany.
Stem cell factor (SCF) and erythropoietin (Epo) effectively support
erythroid cell development in vivo and in vitro. We have studied here
an SCF/Epo-dependent erythroid progenitor cell from cord blood that can
be efficiently amplified in liquid culture to large cell numbers in the
presence of SCF, Epo, insulin-like growth factor-1
(IGF-1), dexamethasone, and estrogen. Additionally, by
changing the culture conditions and by administration of Epo plus
insulin, such progenitor cells effectively undergo terminal differentiation in culture and thereby faithfully recapitulate erythroid cell differentiation in vitro. This SCF/Epo-dependent erythroid progenitor is also present in CD34+ peripheral
blood stem cells and human bone marrow and can be isolated, amplified,
and differentiated in vitro under the same conditions. Thus, highly
homogenous populations of SCF/Epo-dependent erythroid progenitors can
be obtained in large cell numbers that are most suitable for further
biochemical and molecular studies. We demonstrate that such cells
express the recently identified adapter protein p62dok that
is involved in signaling downstream of the c-kit/SCF receptor. Additionally, cells express the cyclin-dependent kinase (CDK) inhibitors p21cip1 and p27kip1 that are highly
induced when cells differentiate. Thus, the in vitro system described
allows the study of molecules and signaling pathways involved in
proliferation or differentiation of human erythroid cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. A. Steiner, Y. Maksimova, V. Schulz, C. Wong, D. Raha, M. C. Mahajan, S. M. Weissman, and P. G. Gallagher
Chromatin Architecture and Transcription Factor Binding Regulate Expression of Erythrocyte Membrane Protein Genes
Mol. Cell. Biol.,
October 15, 2009;
29(20):
5399 - 5412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Fang, M. Menon, W. Kapelle, O. Bogacheva, O. Bogachev, E. Houde, S. Browne, P. Sathyanarayana, and D. M. Wojchowski
EPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblasts
Blood,
October 1, 2007;
110(7):
2361 - 2370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Li, N. Jia, R. Kapur, and K. T. Chun
Cul4A targets p27 for degradation and regulates proliferation, cell cycle exit, and differentiation during erythropoiesis
Blood,
June 1, 2006;
107(11):
4291 - 4299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-R. Koh, M. Janz, M. Y. Mapara, B. Lemke, D. Stirling, B. Dorken, M. Zenke, and S. Lentzsch
Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis
Blood,
May 15, 2005;
105(10):
3833 - 3840.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Munoz-Alonso, J. C. Acosta, C. Richard, M. D. Delgado, J. Sedivy, and J. Leon
p21Cip1 and p27Kip1 Induce Distinct Cell Cycle Effects and Differentiation Programs in Myeloid Leukemia Cells
J. Biol. Chem.,
May 6, 2005;
280(18):
18120 - 18129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hieronymus, T. C. Gust, R. D. Kirsch, T. Jorgas, G. Blendinger, M. Goncharenko, K. Supplitt, S. Rose-John, A. M. Muller, and M. Zenke
Progressive and Controlled Development of Mouse Dendritic Cells from Flt3+CD11b+ Progenitors In Vitro
J. Immunol.,
March 1, 2005;
174(5):
2552 - 2562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ohene-Abuakwa, K. A. Orfali, C. Marius, and S. E. Ball
Two-phase culture in Diamond Blackfan anemia: localization of erythroid defect
Blood,
January 15, 2005;
105(2):
838 - 846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Baik, W. J. DeVito, K. Ballen, P. S. Becker, W. Okulicz, Q. Liu, E. Delpapa, P. Lagiou, S. Sturgeon, D. Trichopoulos, et al.
Association of Fetal Hormone Levels with Stem Cell Potential: Evidence for Early Life Roots of Human Cancer
Cancer Res.,
January 1, 2005;
65(1):
358 - 363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Leberbauer, F. Boulme, G. Unfried, J. Huber, H. Beug, and E. W. Mullner
Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors
Blood,
January 1, 2005;
105(1):
85 - 94.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Aerbajinai, Y. T. Lee, U. Wojda, V. A. Barr, and J. L. Miller
Cloning and Characterization of a Gene Expressed during Terminal Differentiation That Encodes a Novel Inhibitor of Growth
J. Biol. Chem.,
January 16, 2004;
279(3):
1916 - 1921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Li, M. P. Menon, V. G. Karur, S. Hegde, and D. M. Wojchowski
Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells
Blood,
November 1, 2003;
102(9):
3147 - 3153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Bouscary, F. Pene, Y.-E. Claessens, O. Muller, S. Chretien, M. Fontenay-Roupie, S. Gisselbrecht, P. Mayeux, and C. Lacombe
Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation
Blood,
May 1, 2003;
101(9):
3436 - 3443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gabbianelli, U. Testa, A. Massa, O. Morsilli, E. Saulle, N. M. Sposi, E. Petrucci, G. Mariani, and C. Peschle
HbF reactivation in sibling BFU-E colonies: synergistic interaction of kit ligand with low-dose dexamethasone
Blood,
April 1, 2003;
101(7):
2826 - 2832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. E. Nicolini, S. Imren, I.-H. Oh, R. K. Humphries, P. Leboulch, M. E. Fabry, R. L. Nagel, and C. J. Eaves
Expression of a human beta -globin transgene in erythroid cells derived from retrovirally transduced transplantable human fetal liver and cord blood cells
Blood,
July 30, 2002;
100(4):
1257 - 1264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Burns, M. O. Arcasoy, L. Li, E. Kurian, K. Selander, P. D. Emanuel, and K. W. Harris
Purification and characterization of the yeast-expressed erythropoietin mutant Epo (R103A), a specific inhibitor of human primary hematopoietic cell erythropoiesis
Blood,
May 29, 2002;
99(12):
4400 - 4405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-f. Wang and A. D. Friedman
CCAAT/enhancer-binding proteins are required for granulopoiesis independent of their induction of the granulocyte colony-stimulating factor receptor
Blood,
April 15, 2002;
99(8):
2776 - 2785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-E. Claessens, D. Bouscary, J.-M. Dupont, F. Picard, J. Melle, S. Gisselbrecht, C. Lacombe, F. Dreyfus, P. Mayeux, and M. Fontenay-Roupie
In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis
Blood,
March 1, 2002;
99(5):
1594 - 1601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Miller, D. W. Heilman, and D. M. Wojchowski
Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor forms
Blood,
February 1, 2002;
99(3):
898 - 904.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Reeves, S. Zamudio, T. E. Dahms, I. Asmus, B. Braun, G. E. Butterfield, R. G. McCullough, S. R. Muza, P. B. Rock, and L. G. Moore
Erythropoiesis in women during 11 days at 4,300 m is not affected by menstrual cycle phase
J Appl Physiol,
December 1, 2001;
91(6):
2579 - 2586.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. P. Koritschoner, J. Madruga, S. Knespel, G. Blendinger, B. Anzinger, A. Otto, M. Zenke, and P. Bartunek
The Nuclear Orphan Receptor TR4 Promotes Proliferation of Myeloid Progenitor Cells
Cell Growth Differ.,
November 1, 2001;
12(11):
563 - 572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. de Wynter, C. M. Heyworth, N. Mukaida, E. Jaworska, A. Weffort-Santos, K. Matushima, and N. G. Testa
CCR1 chemokine receptor expression isolates erythroid from granulocyte-macrophage progenitors
J. Leukoc. Biol.,
September 1, 2001;
70(3):
455 - 460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. N. Geiger, G. T. Knudsen, L. Panek, A. K. Pandit, M. D. Yoder, K. A. Lord, C. L. Creasy, B. M. Burns, P. Gaines, S. B. Dillon, et al.
mDYRK3 kinase is expressed selectively in late erythroid progenitor cells and attenuates colony-forming unit-erythroid development
Blood,
February 15, 2001;
97(4):
901 - 910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W. Zandstra, D. A. Lauffenburger, and C. J. Eaves
A ligand-receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesis
Blood,
August 15, 2000;
96(4):
1215 - 1222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Shiotsu, K. Yamashita, F. Kanai, Y. Ikuina, C. Murakata, M. Teramura, H. Mizoguchi, T. Tamaoki, and S. Akinaga
Chemoprotective effects of KF41399, a derivative of carbazole compounds, on nimustine-induced thrombocytopenia
Blood,
June 15, 2000;
95(12):
3771 - 3780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Myklebust, E. B. Smeland, D. Josefsen, and M. Sioud
Protein kinase C-alpha isoform is involved in erythropoietin-induced erythroid differentiation of CD34+ progenitor cells from human bone marrow
Blood,
January 15, 2000;
95(2):
510 - 518.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Miller, Z. Y. Liu, C. T. Noguchi, and D. M. Wojchowski
A Minimal Cytoplasmic Subdomain of the Erythropoietin Receptor Mediates Erythroid and Megakaryocytic Cell Development
Blood,
November 15, 1999;
94(10):
3381 - 3387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Fujisaki, M. G. Berger, S. Rose-John, and C. J. Eaves
Rapid Differentiation of a Rare Subset of Adult Human Lin-CD34-CD38- Cells Stimulated by Multiple Growth Factors In Vitro
Blood,
September 15, 1999;
94(6):
1926 - 1932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. von Lindern, W. Zauner, G. Mellitzer, P. Steinlein, G. Fritsch, K. Huber, B. Lowenberg, and H. Beug
The Glucocorticoid Receptor Cooperates With the Erythropoietin Receptor and c-Kit to Enhance and Sustain Proliferation of Erythroid Progenitors In Vitro
Blood,
July 15, 1999;
94(2):
550 - 559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Pircher, J. N. Geiger, D. Zhang, C. P. Miller, P. Gaines, and D. M. Wojchowski
Integrative Signaling by Minimal Erythropoietin Receptor Forms and c-Kit
J. Biol. Chem.,
March 16, 2001;
276(12):
8995 - 9002.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|